No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Fluicell AB (publ) is a global provider of cutting-edge single-cell discovery platforms, catering to applications in biomedicine, drug development, and bioprinting. The company's product line includes the BioPen PRIME and BioPen FLEX microfluidic systems, engineered for precise localized solution delivery during single-cell experiments and for managing the chemical microenvironment of individual intact cells within tissue or cell cultures. Furthermore, Fluicell offers the Dynaflow Resolve system, a specialized platform for secondary ion channel screening that enables the measurement of various ion channel currents in a patch-clamp recording configuration. This Swedish company, headquartered in Gothenburg, was founded in 2012.
www.fluicell.comNo one on the platform currently holds FLUI.ST.
No tracked institution reports a position in FLUI.ST as of their last filing.
No one on the platform has traded FLUI.ST yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $69M | +52.1% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| FLUI.STFluicell AB (publ) | $32.80 | -1.80% | $45M | — |
| 2CUREX.ST2cureX AB (publ) | $0.42 | -12.13% | $11M | — |
| APTA.STAptahem AB (publ) | $0.38 | -14.35% | $10M | — |
| CMH.STChordate Medical Holding AB (publ) | $0.10 | -37.50% | $269962 | — |
| GUARD.STGuard Therapeutics International AB (publ) | $1.47 | +0.00% | $30M | — |
| LIDDS.STLIDDS AB (publ) | $0.02 | +0.00% | $3M | — |
| ODI.STODI Pharma AB | $2.04 | -1.92% | $37M | — |
Source: Financial Modeling Prep · peers by sector/industry